- Home
- RVPH vs FDSB Comparison
RVPH vs FDSB Comparison
Compare RVPH & FDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- FDSB
- Stock Information
- Founded
- RVPH 2006
- FDSB 1926
- Country
- RVPH United States
- FDSB United States
- Employees
- RVPH N/A
- FDSB N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- FDSB
- Sector
- RVPH Health Care
- FDSB
- Exchange
- RVPH Nasdaq
- FDSB NYSE
- Market Cap
- RVPH 32.8M
- FDSB 69.2M
- IPO Year
- RVPH N/A
- FDSB N/A
- Fundamental
- Price
- RVPH $0.34
- FDSB $12.25
- Analyst Decision
- RVPH Strong Buy
- FDSB
- Analyst Count
- RVPH 5
- FDSB 0
- Target Price
- RVPH $9.00
- FDSB N/A
- AVG Volume (30 Days)
- RVPH 2.4M
- FDSB 13.5K
- Earning Date
- RVPH 08-13-2025
- FDSB 08-15-2025
- Dividend Yield
- RVPH N/A
- FDSB N/A
- EPS Growth
- RVPH N/A
- FDSB N/A
- EPS
- RVPH N/A
- FDSB 0.02
- Revenue
- RVPH N/A
- FDSB $12,612,000.00
- Revenue This Year
- RVPH N/A
- FDSB N/A
- Revenue Next Year
- RVPH N/A
- FDSB N/A
- P/E Ratio
- RVPH N/A
- FDSB $515.94
- Revenue Growth
- RVPH N/A
- FDSB 40.41
- 52 Week Low
- RVPH $0.30
- FDSB $9.85
- 52 Week High
- RVPH $4.28
- FDSB $14.50
- Technical
- Relative Strength Index (RSI)
- RVPH 27.45
- FDSB N/A
- Support Level
- RVPH $0.72
- FDSB N/A
- Resistance Level
- RVPH $0.83
- FDSB N/A
- Average True Range (ATR)
- RVPH 0.07
- FDSB 0.00
- MACD
- RVPH -0.03
- FDSB 0.00
- Stochastic Oscillator
- RVPH 9.67
- FDSB 0.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About FDSB FIFTH DISTRICT BANCORP INC.
Fifth District Bancorp inc is a holding company of Fifth District. Fifth District portfolio consists primarily of fixed-rate one- to four-family residential mortgage loans also originate construction loans, home equity loans, home equity lines of credit, land loans, and share loans (loans secured by deposit accounts at Fifth District) and purchase commercial business loans. The company offer a variety of deposit accounts including checking accounts, money market accounts, and certificates of deposit. In addition, it offers electronic banking services including mobile banking, on-line banking, telephone banking, bill pay, and electronic funds transfer via SmartPay.